BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25303481)

  • 21. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma.
    Karatzas T; Vasileiadis I; Kapetanakis S; Karakostas E; Chrousos G; Kouraklis G
    Am J Surg; 2013 Oct; 206(4):586-93. PubMed ID: 23790258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma.
    Paulson L; Shindo M; Schuff K; Corless C
    Arch Otolaryngol Head Neck Surg; 2012 Jan; 138(1):44-9. PubMed ID: 22249628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High recurrent rate of multicentric papillary thyroid carcinoma.
    Lin JD; Chao TC; Hsueh C; Kuo SF
    Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
    Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
    Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical implications of bilateral lateral cervical lymph node metastasis in papillary thyroid cancer: a risk factor for lung metastasis.
    Lee YS; Lim YS; Lee JC; Wang SG; Kim IJ; Son SM; Lee BJ
    Ann Surg Oncol; 2011 Nov; 18(12):3486-92. PubMed ID: 21553141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence.
    Roh JL; Kim JM; Park CI
    Ann Surg Oncol; 2011 Aug; 18(8):2245-50. PubMed ID: 21327454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer.
    Shindo M; Wu JC; Park EE; Tanzella F
    Arch Otolaryngol Head Neck Surg; 2006 Jun; 132(6):650-4. PubMed ID: 16785411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An analysis of factors predicting lateral cervical nodal metastases in papillary carcinoma of the thyroid.
    Hunt JP; Buchmann LO; Wang L; Abraham D
    Arch Otolaryngol Head Neck Surg; 2011 Nov; 137(11):1141-5. PubMed ID: 22106241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.
    Kazaure HS; Roman SA; Sosa JA
    Ann Surg Oncol; 2012 Jun; 19(6):1874-80. PubMed ID: 22065195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
    Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
    Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroid cancer and lymph node metastases.
    Clark OH
    J Surg Oncol; 2011 May; 103(6):615-8. PubMed ID: 21480256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.
    Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH
    Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive value of the Delphian and level VI nodes in papillary thyroid cancer.
    Isaacs JD; McMullen TP; Sidhu SB; Sywak MS; Robinson BG; Delbridge LW
    ANZ J Surg; 2010 Nov; 80(11):834-8. PubMed ID: 20969694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma.
    Ryu IS; Song CI; Choi SH; Roh JL; Nam SY; Kim SY
    Ann Surg Oncol; 2014 Jan; 21(1):277-83. PubMed ID: 24006096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the prognostic significance of lymph node related characteristics in papillary thyroid carcinoma patients presenting with pre- or intra-operative evidence of cervical lymph node metastases.
    Soudry E; Hilly O; Preis M; Hadar T; Segal K; Bachar G; Feinmesser R
    J Laryngol Otol; 2014 Mar; 128(3):284-8. PubMed ID: 24636046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does extracapsular extension impact the prognosis of papillary thyroid microcarcinoma?
    Chéreau N; Buffet C; Trésallet C; Tissier F; Golmard JL; Leenhardt L; Menegaux F
    Ann Surg Oncol; 2014 May; 21(5):1659-64. PubMed ID: 24394985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma.
    Kim EY; Kim WG; Kim WB; Kim TY; Kim JM; Ryu JS; Hong SJ; Gong G; Shong YK
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):581-6. PubMed ID: 19222495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiated thyroid cancer: role of the lymph node dissection.
    Caglià P; Zappulla E; Costa S; Tracia M; Veroux M; Russo V; Borzì L; Lucifora B; Patanè G; Tracia L; Amodeo C
    G Chir; 2010; 31(6-7):293-5. PubMed ID: 20646374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases.
    Pellegriti G; Scollo C; Lumera G; Regalbuto C; Vigneri R; Belfiore A
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3713-20. PubMed ID: 15292295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.